{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:00:25Z","timestamp":1784930425028,"version":"3.55.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The clinical course, outcome, risk of malignancy, and causes of mortality in the pediatric dyskeratosis congenita (DC) population have been described in a few studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Data of patients with DC enrolled in the Canadian Inherited Marrow Failure Registry (CIMFR) between January 2001 and December 2021 were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Forty-three patients with DC were diagnosed at a median age of 9 years. The underlying mutated genes included\n                      <jats:italic toggle=\"yes\">DKC1, PARN, RTEL1, TERC, TERT<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">TINF2<\/jats:italic>\n                      . Nine patients developed severe bone marrow failure (BMF). Presence of severe BMF was associated with a higher risk of mortality (HR: 7.5). Patients with DC who were diagnosed at a younger age had lower overall survival. No pediatric patients developed malignancy. Eleven patients received a hematopoietic stem cell transplant. Ten patients died due to organ dysfunction, mostly related to DC. All 5\n                      <jats:italic toggle=\"yes\">TINF2<\/jats:italic>\n                      patients died, but no patients died in the\n                      <jats:italic toggle=\"yes\">TERT, TERC<\/jats:italic>\n                      , or\n                      <jats:italic toggle=\"yes\">RTEL1<\/jats:italic>\n                      groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      Pediatric patients with DC have a high mortality rate related to BMF and organ dysfunction, but malignancy is uncommon in this age group. Earlier age at diagnosis and presence of severe BMF could be risk factors for mortality. Patients with the\n                      <jats:italic toggle=\"yes\">TINF2<\/jats:italic>\n                      genotype tend to have a worse outcome than patients with\n                      <jats:italic toggle=\"yes\">RTEL1, TERC<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">TERT<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mph.0000000000003222","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:00:47Z","timestamp":1781100047000},"page":"287-297","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of Dyskeratosis Congenita: Results From the Canadian Inherited Marrow Failure Registry"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5780-5668","authenticated-orcid":false,"given":"Mohammed","family":"Al Nuaimi","sequence":"first","affiliation":[{"name":"The Marrow Failure and Myelodysplasia Program, Haematology Section, Division of Haematology\/Oncology, Department of Paediatrics, Hospital for Sick Children, Toronto"},{"name":"Institute of Medical Science, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Catala","sequence":"additional","affiliation":[{"name":"The Marrow Failure and Myelodysplasia Program, Haematology Section, Division of Haematology\/Oncology, Department of Paediatrics, Hospital for Sick Children, Toronto"},{"name":"Program in Genetics and Genome Biology, Research Institute, Hospital for Sick Children, Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Elias","sequence":"additional","affiliation":[{"name":"The Marrow Failure and Myelodysplasia Program, Haematology Section, Division of Haematology\/Oncology, Department of Paediatrics, Hospital for Sick Children, Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon J.","family":"Lim","sequence":"additional","affiliation":[{"name":"Program in Genetics and Genome Biology, Research Institute, Hospital for Sick Children, Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bozana","family":"Zlateska","sequence":"additional","affiliation":[{"name":"The Marrow Failure and Myelodysplasia Program, Haematology Section, Division of Haematology\/Oncology, Department of Paediatrics, Hospital for Sick Children, Toronto"},{"name":"Program in Genetics and Genome Biology, Research Institute, Hospital for Sick Children, Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Klaassen","sequence":"additional","affiliation":[{"name":"IWK Health Centre, Halifax, Nova Scotia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey D.E.","family":"Cuvelier","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Oncology, Montreal Children\u2019s Hospital, Montreal, QC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, London Health Sciences Centre, London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Rayar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, McMaster University, Hamilton, ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6864-0598","authenticated-orcid":false,"given":"MacGregor","family":"Steele","sequence":"additional","affiliation":[{"name":"Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves D.","family":"Pastore","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire, Sherbrooke, QC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Abish","sequence":"additional","affiliation":[{"name":"Jim Pattison Children\u2019s Hospital, Saskatoon, SK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumitra","family":"Tole","sequence":"additional","affiliation":[{"name":"British Columbia Children\u2019s Hospital, Vancouver, British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky R.","family":"Breakey","sequence":"additional","affiliation":[{"name":"Alberta Children\u2019s Hospital, Calgary, Alberta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josee","family":"Brossard","sequence":"additional","affiliation":[{"name":"Kingston General Hospital, Kingston, ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roona","family":"Sinha","sequence":"additional","affiliation":[{"name":"Division iHOPE, Department of Pediatrics, University of Alberta, Edmonton, AB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Wheaton","sequence":"additional","affiliation":[{"name":"CHU Sainte-Justine, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Goodyear","sequence":"additional","affiliation":[{"name":"Child and population Health Sciences, Research Institute, Division of Hematology\/Oncology, Department of Pediatrics, Hospital for Sick Children, Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Lipton","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Eastern Ontario, Ottawa, Ontario"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Michon","sequence":"additional","affiliation":[{"name":"Pediatric Hematology\/Oncology, Janeway Child Health Centre, St. John\u2019s, NF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Corriveau-Bourque","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Quebec, Sainte-Foy, QC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigal","family":"Dror","sequence":"additional","affiliation":[{"name":"The Marrow Failure and Myelodysplasia Program, Haematology Section, Division of Haematology\/Oncology, Department of Paediatrics, Hospital for Sick Children, Toronto"},{"name":"Program in Genetics and Genome Biology, Research Institute, Hospital for Sick Children, Toronto"},{"name":"CancerCare Manitoba, University of Manitoba, Winnipeg, Manitoba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Cada","sequence":"additional","affiliation":[{"name":"The Marrow Failure and Myelodysplasia Program, Haematology Section, Division of Haematology\/Oncology, Department of Paediatrics, Hospital for Sick Children, Toronto"},{"name":"Program in Genetics and Genome Biology, Research Institute, Hospital for Sick Children, Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"R2-20260724","first-page":"219","article-title":"Atrophia cutis reticularis cum pigmentione, dystrophia unguium et leukokeratosis oris","volume":"5","author":"Zinsser","year":"1906","journal-title":"Ikonogr Dermatol"},{"key":"R3-20260724","first-page":"685","article-title":"A unique case of reticular pigmentation of the skin with atrophy","volume":"13","author":"Engman","year":"1926","journal-title":"Arch Derm Syph Suppl"},{"key":"R4-20260724","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archderm.1930.01440070079008","article-title":"Dyskeratosis congenita with pigmentation, dystrophia unguis and leukokeratosis oris","volume":"21","author":"Cole","year":"1930","journal-title":"Arch Derm Syph Suppl"},{"key":"R5-20260724","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/archderm.1963.01590210098015","article-title":"Dyskeratosis congenita: first report of its occurrence in a female and a review of the literature","volume":"88","author":"Sorrow","year":"1963","journal-title":"Arch Dermatol"},{"key":"R6-20260724","first-page":"409","article-title":"Dyskeratosis congenita with Fanconi-type anemia, investigations of immunologic and other defects","volume":"19","author":"Scoggins","year":"1971","journal-title":"Clin Rcs"},{"key":"R7-20260724","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.2000.02109.x","article-title":"Dyskeratosis congenita in all its forms","volume":"110","author":"Dokal","year":"2000","journal-title":"Br J Haematol"},{"key":"R8-20260724","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1182\/blood-2005-07-2622","article-title":"Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation","volume":"107","author":"Vulliamy","year":"2006","journal-title":"Blood"},{"key":"R10-20260724","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1651-2227.1970.tb08986.x","article-title":"Congenital hypoplastic thrombocytopenia and cerebral malformations in two brothers","volume":"59","author":"Hoyeraal","year":"1970","journal-title":"Acta Paediatr Scand"},{"key":"R11-20260724","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1651-2227.1988.tb10751.x","article-title":"A syndrome of progressive pancytopenia with microcephaly, cerebellar hypoplasia and growth failure","volume":"77","author":"Hreidarsson","year":"1988","journal-title":"Acta Paediatr Scand"},{"key":"R12-20260724","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/bjh.13442","article-title":"Unraveling the pathogenesis of Hoyeraal-Hreidarsson syndrome, a complex telomere biology disorder","volume":"170","author":"Glousker","year":"2015","journal-title":"Br J Haematol"},{"key":"R13-20260724","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.pcl.2013.09.007","article-title":"The inherited bone marrow failure syndromes","volume":"60","author":"Deborah Chirnomas","year":"2013","journal-title":"Pediatr Clin North Am"},{"key":"R15-20260724","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/jmg.29.9.673","article-title":"Bilateral retinopathy, aplastic anaemia, and central nervous system abnormalities: a new syndrome?","volume":"29","author":"Revesz","year":"1992","journal-title":"J Med Genet"},{"key":"R16-20260724","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-2003-43552","article-title":"Coats\u2019 plus: a progressive familial syndrome of bilateral Coats\u2019 disease, characteristic cerebral calcification, leukoencephalopathy, slow pre- and post-natal linear growth and defects of bone marrow and integument","volume":"35","author":"Crow","year":"2004","journal-title":"Neuropediatrics"},{"key":"R18-20260724","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s000180300042","article-title":"Human genome and diseases: dyskeratosis congenita","volume":"60","author":"Marrone","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"R19-20260724","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.seminhematol.2006.04.001","article-title":"Dyskeratosis congenita","volume":"43","author":"Vulliamy","year":"2006","journal-title":"Semin Hematol"},{"key":"R20-20260724","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41576-022-00527-z","article-title":"Genetics of human telomere biology disorders","volume":"24","author":"Revy","year":"2023","journal-title":"Nat Rev Genet"},{"key":"R21-20260724","doi-asserted-by":"crossref","first-page":"100064","DOI":"10.1074\/jbc.REV120.014017","article-title":"Molecular mechanisms of telomere biology disorders","volume":"296","author":"Grill","year":"2021","journal-title":"J Biol Chem"},{"key":"R22-20260724","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1365-2141.1999.01690.x","article-title":"Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1","volume":"107","author":"Knight","year":"1999","journal-title":"Br J Haematol"},{"key":"R23-20260724","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3324\/haematol.2016.147769","article-title":"Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosis","volume":"101","author":"Walne","year":"2016","journal-title":"Haematologica"},{"key":"R24-20260724","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/jmedgenet-2015-103292","article-title":"Developmental delay caused by mutations in poly(A)-specific ribonuclease (PARN)","volume":"52","author":"Dhanraj","year":"2015","journal-title":"J Med Genet"},{"key":"R25-20260724","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1182\/hematology.2022000394","article-title":"Dyskeratosis congenita and telomere biology disorders","volume":"2022","author":"Savage","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R26-20260724","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.seminhematol.2013.09.002","article-title":"Genomic characterization of the inherited bone marrow failure syndromes","volume":"50","author":"Khincha","year":"2013","journal-title":"Semin Hematol"},{"key":"R27-20260724","first-page":"157","article-title":"The diagnosis and treatment of dyskeratosis congenita: a review","volume":"5","author":"Soledad Fern\u00e1ndez Garc\u00eda","year":"2014","journal-title":"J Blood Med"},{"key":"R28-20260724","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood.2021011980","article-title":"Gain-of-function mutations in RPA1 cause a syndrome with short telomeres and somatic genetic rescue","volume":"139","author":"Sharma","year":"2022","journal-title":"Blood"},{"key":"R29-20260724","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1182\/blood-2008-12-192880","article-title":"Cancer in dyskeratosis congenita","volume":"113","author":"Alter","year":"2009","journal-title":"Blood"},{"key":"R30-20260724","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.2010.08212.x","article-title":"Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study","volume":"150","author":"Alter","year":"2010","journal-title":"Br J Haematol"},{"key":"R31-20260724","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/cge.13158","article-title":"Molecular analysis and genotype-phenotype correlation of Diamond-Blackfan anemia","volume":"93","author":"Arbiv","year":"2018","journal-title":"Clin Genet"},{"issue":"1-2","key":"R32-20260724","first-page":"73","article-title":"Genotype-phenotype correlations in Fanconi anemia","volume":"668","author":"Neveling","year":"2009","journal-title":"Mutat Res"},{"key":"R33-20260724","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1182\/blood.2021013523","article-title":"Disease progression and clinical outcomes in telomere biology disorders","volume":"139","author":"Niewisch","year":"2022","journal-title":"Blood"},{"key":"R34-20260724","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/jmg.2011.089821","article-title":"Genetic analysis of inherited bone marrow failure syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutations","volume":"48","author":"Tsangaris","year":"2011","journal-title":"J Med Genet"},{"key":"R35-20260724","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/GIM.0b013e3181f415b5","article-title":"The genetics and clinical manifestations of telomere biology disorders","volume":"12","author":"Savage","year":"2010","journal-title":"Genet Med"},{"key":"R36-20260724","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/ejhg.2014.170","article-title":"Clinical utility gene card for: dyskeratosis congenita - update 2015","volume":"23","author":"Dokal","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"R38-20260724","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jmedgenet-2015-103270","article-title":"Improving diagnostic precision, care and syndrome definitions using comprehensive next-generation sequencing for the inherited bone marrow failure syndromes","volume":"52","author":"Ghemlas","year":"2015","journal-title":"J Med Genet"},{"key":"R39-20260724","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41525-019-0104-9","article-title":"Reanalysing genomic data by normalized coverage values uncovers CNVs in bone marrow failure gene panels","volume":"4","author":"Lauhasurayotin","year":"2019","journal-title":"NPJ Genom Med"},{"key":"R40-20260724","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2009.07842.x","article-title":"Guidelines for the diagnosis and management of aplastic anaemia","volume":"147","author":"Marsh","year":"2009","journal-title":"Br J Haematol"},{"key":"R41-20260724","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3324\/haematol.2014.117457","article-title":"The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes","volume":"100","author":"Cada","year":"2015","journal-title":"Haematologica"},{"key":"R42-20260724","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1182\/asheducation-2016.1.598","article-title":"Myelodysplastic and myeloproliferative disorders of childhood","volume":"2016","author":"Hasle","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R43-20260724","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.leu.2402765","article-title":"A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases","volume":"17","author":"Hasle","year":"2003","journal-title":"Leukemia"},{"key":"R44-20260724","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/asheducation-2011.1.480","article-title":"Dyskeratosis Congenita","volume":"2011","author":"Dokal","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R45-20260724","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1399-0004.2007.00923.x","article-title":"Dyskeratosis congenita: a genetic disorder of many faces","volume":"73","author":"Kirwan","year":"2008","journal-title":"Clin Genet"},{"key":"R47-20260724","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.blre.2010.03.002","article-title":"Pathophysiology and management of inherited bone marrow failure syndromes","volume":"24","author":"Shimamura","year":"2010","journal-title":"Blood Rev"},{"key":"R48-20260724","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/bjh.15495","article-title":"Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita","volume":"183","author":"Fioredda","year":"2018","journal-title":"Br J Haematol"},{"key":"R49-20260724","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17474086.2022.2108784","article-title":"The biology and management of dyskeratosis congenita and related disorders of telomeres","volume":"15","author":"Tummala","year":"2022","journal-title":"Expert Rev Hematol"},{"key":"R50-20260724","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1182\/blood-2008-05-153445","article-title":"TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes","volume":"112","author":"Walne","year":"2008","journal-title":"Blood"},{"key":"R51-20260724","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ajhg.2007.10.004","article-title":"TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita","volume":"82","author":"Savage","year":"2008","journal-title":"Am J Hum Genet"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:00:27Z","timestamp":1784926827000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003222","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"2025-10-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}